Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Suzanne J. Francart"'
Publikováno v:
American Journal of Health-System Pharmacy.
Purpose An increasing focus on driving margin has pushed health-system pharmacy departments to find new ways of generating new or protecting existing revenue. At UNC Health, a dedicated pharmacy revenue integrity (PRI) team has been operating since 2
Publikováno v:
Journal of Pharmacy Practice. 35:551-558
Purpose: The purpose of this study is to assess the impact of a clinic embedded Medication Assistance Program (MAP) specialist on the prescription benefit prior authorization (PA) process and provider satisfaction in an adult pulmonary clinic. Method
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
Purpose A common denial trend that occurs with “outpatient medical benefit drugs” (ie, medications covered by a medical benefit plan and administered in an outpatient visit) is payers not requiring or permitting prior authorization (PA) proactive
Publikováno v:
Oncology Issues. 35:30-36
In an era of soaring drug prices, payers have developed complex strategies to manage costs and ensure clinically appropriate prescribing in the outpatient environment.1–3 Some of the most frequentl...
Autor:
Stephanie J Jean, Suzanne J. Francart, Daniel H Schenkat, Lindsey B. Amerine, Stephen F. Eckel, John M. Valgus, Matthew H. Lamm, Nathan Barnes, Samuel M. Eberwein
Publikováno v:
American Journal of Health-System Pharmacy. 77:560-567
Purpose To evaluate the impact of remote sterile product pharmacist checks when used with a gravimetric-based technology-assisted workflow (TAWF) system on product checking accuracy, pharmacist review time, workload sharing, cost savings, and staff p
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(8)
Introduction Medication prior authorizations (PA) required by insurance payers can be time-consuming to complete and may lead to delays in treatment for cancer patients. The primary objective of this study is to assess the impact of Medication Assist
Autor:
Scott W. Savage, Ian Willoughby, Elissa King, Kayla M Waldron, Suzanne J. Francart, Kevin N Hansen, Ashley L Pappas, Matthew H. Lamm, Lindsey B. Amerine, Jami Mann
Publikováno v:
American Journal of Health-System Pharmacy. 76:1007-1009
Autor:
Suzanne J. Francart, Brynja R. Gudmundsdottir, Rickard E. Malmström, Emily M. Hawes, L. R. Letertre, Robert C. Gosselin, Pall T. Onundarson, M. Skeppholm, Stephan Moll, Charles W. Francis
Publikováno v:
Journal of Thrombosis and Haemostasis. 14:1043-1053
UNLABELLED Essentials Simple and fast assaying of different anticoagulants (ACs) is useful in emergent situations. We used highly diluted prothrombin time (dPT) or highly diluted Fiix-PT (dFiix-PT) to assay ACs. Both tests could quantify target speci
Autor:
Suzanne J. Francart, Dorothy M. Adcock, William E. Dager, Robert C. Gosselin, Emily M. Hawes, Stephan Moll
Publikováno v:
Annals of Pharmacotherapy. 49:777-783
Background: Determination of plasma rivaroxaban concentration may be necessary in certain clinical situations. Rivaroxaban concentration can be accurately and rapidly determined using a chromogenic anti–activated factor X (factor Xa) assay with spe
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 18:45-52
OBJECTIVES The primary objective was to evaluate the correlation between maintenance dose and response rates in neonates less than 28 weeks gestational age. Secondary objectives included clinical indicators of response (number of weight adjustments,